The small study in patients with a rare disorder that causes liver and lung damage showed the potential for precisely ...
According to Roche subsidiary Genentech, which announced the label expansion on Monday, TNKase is the first new drug for ...
--(BUSINESS WIRE)--Genentech, a member of the Roche Group ... respiratory tract infections including infections of the lungs, cold symptoms, and pain or swelling of the nose or throat viral ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results